Search Login Register

rosiglitazone (Avandia) Summary

Description: a peroxisome proliferator-activated receptor gamma agonist; reduces lipid availability, improves insulin action & glucoregulation; Avandia is tradename for the rosiglitazone maleate

Also Known As: Avandia; 5-((4-(2-methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate; BRL 49653; BRL-49653; BRL49653 Show All >>

Networked: 1877 relevant articles (211 outcomes, 463 trials/studies) for this Drug

Key Diseases for which rosiglitazone is Relevant

  1. Insulin Resistance : 42 outcomes 39 studies in 256 results
  2. Type 2 Diabetes Mellitus (MODY) : 26 outcomes 61 studies in 256 results
  3. Inflammation : 16 outcomes 28 studies in 137 results
  4. Body Weight (Weight, Body) : 11 outcomes 10 studies in 121 results
  5. Hyperglycemia : 8 outcomes 7 studies in 44 results
Show All >>

Drugs Related to rosiglitazone

  1. Insulin (Novolin)
  2. PPAR gamma
  3. Metformin (Glucophage)
  4. Glucose (Dextrose)
  5. pioglitazone (Actos)
  6. Adiponectin
  7. 2,4-thiazolidinedione (thiazolidinedione)
  8. Thiazolidinediones
  9. Fenofibrate (CiL)
  10. Glyburide (Glibenclamide)
Show All >>

Therapies Related to rosiglitazone

  1. Aftercare (After-Treatment)
  2. Transplantation (Transplant Recipients)
  3. Transplants (Transplant)
  4. Kidney Transplantation
  5. Homologous Transplantation (Allograft)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.